Sign in

CIK 0000822370

  • Non-accelerated filer
  • Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870419387
Phone
+1 310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Grant or award Director acquired 4,500 shares (grant or award)
  2. 4 Grant or award Director acquired 4,500 shares (grant or award)
  3. 4 Grant or award Chief Executive Officer acquired 11,205 shares (grant or award)
  4. 4 Derivatives Options or other derivatives
  5. 4/A Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4/A Grant or award Director acquired 25,000 shares (grant or award)
  8. 4 Grant or award Chief Executive Officer acquired 34,380 shares (grant or award)
  9. 4 Grant or award Director acquired 25,000 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Director bought 10,000 shares at $3.44 ($34,378)
  13. 4 Open-market buy Director bought 4,552 shares at an average $3.81 ($17,337)
  14. 4 Open-market buy Director bought 15,000 shares at $3.65 ($54,735)
  15. 4 Grant or award Chief Executive Officer acquired 7,500 shares (grant or award)
  16. 4 Grant or award Chief Financial Officer acquired 7,500 shares (grant or award)
  17. 4 Grant or award Director acquired 7,500 shares (grant or award)
  18. 4 Grant or award 10% owner acquired 12,000 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 12,000 shares (grant or award)

Page 13 of 25 · 488 filings